Latest Articles
Robotic Surgery Systems for Endometrial Cancer Market Emerging Trends and Growth Prospects 2034 - openPR.com
Robotic Surgery Systems for Endometrial Cancer Market Emerging Trends and Growth Prospects 2034 openPR.com
Published: May 12, 2025, 10:53 a.m.
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer - Nature
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer Nature
Published: May 10, 2025, 10:19 a.m.
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer - OncLive
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer OncLive
Published: May 9, 2025, 11:26 p.m.
Endometrial Cancer Phase III Shows Molecular Profiling Personalizes Treatment - Inside Precision Medicine
Endometrial Cancer Phase III Shows Molecular Profiling Personalizes Treatment Inside Precision Medicine
Published: May 7, 2025, 6:12 p.m.
Endometrial Cancer Phase III Shows Molecular Profiling, Personalizes Treatment - Inside Precision Medicine
Endometrial Cancer Phase III Shows Molecular Profiling, Personalizes Treatment Inside Precision Medicine
Published: May 7, 2025, 6:12 p.m.
Molecular profiling key to reduce radiation for women with endometrial cancer: Study - thehawk.in
Molecular profiling key to reduce radiation for women with endometrial cancer: Study thehawk.in
Published: May 7, 2025, 4 p.m.
A Radiomic-based model to predict the depth of myometrial invasion in endometrial cancer on ultrasound images - Nature
A Radiomic-based model to predict the depth of myometrial invasion in endometrial cancer on ultrasound images Nature
Published: May 7, 2025, 10:05 a.m.
Molecular Profiling May Optimize Treatment for Endometrial Cancer - The ASCO Post
Molecular Profiling May Optimize Treatment for Endometrial Cancer The ASCO Post
Published: May 6, 2025, 8 p.m.
DUO-E Post Hoc Analysis Suggests Potential for Biomarker-Optimized pMMR Endometrial Cancer Management - OncLive
DUO-E Post Hoc Analysis Suggests Potential for Biomarker-Optimized pMMR Endometrial Cancer Management OncLive
Published: May 6, 2025, 2:01 p.m.
Mechanism of miR-200b-3p-induced FOSL2 inhibition of endometrial cancer cell proliferation and metastasis - Nature
Mechanism of miR-200b-3p-induced FOSL2 inhibition of endometrial cancer cell proliferation and metastasis Nature
Published: May 6, 2025, 3:21 a.m.
Link copied to clipboard!